Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Oragenics
3158
Oragenics
Technology
Biotechnology
Health Care
Medical
Pharmaceuticals
We are a biopharmaceutical company focused primarily on oral probiotics products and novel antibiotics for humans and companion pets.
Suggest edits
Type
B2b
Founded
1996
Raised
$7.7M
Follow us
Companies in the same industry
Oramed Pharmaceuticals
Neos Therapeutics, Inc.
FlowMetric
Aclaris Therapeutics, Inc.
SyntheX
Stellar Biotechnologies
CANbridge Life Sciences Ltd.
Antengene Corporation
Aurealis Pharma
pnuvax
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
$3,000,000
Post-IPO equity - 2017
$4,670,000
Venture capital - 2016
Team Size
1–10
Employees
I work here
Location
United States
Headquarters
Explore United States
$3,000,000
Post-IPO equity
businesswire
Oragenics Announces Completion of Second Closing of $3.0 Million Preferred Stock Private Placement
